Neurontin (Gabapentin) for Myeloma

Overview
Neurontin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat postherpetic neuralgia and some types of seizures. In people with myeloma, Neurontin is sometimes prescribed off-label to treat neuropathic (nerve) pain, a common side effect of myeloma treatment. Neurontin is also referred to by its drug name, gabapentin.

Neurontin is an anticonvulsant, or drug that controls seizures. Neurontin is believed to work on certain types of pain by reducing pain signals sent by damaged nerves.

How do I take it?
Prescribing information states that Neurontin should be taken three times a day.

Neurontin comes in tablet, capsule, and liquid solution forms.

Side effects
The FDA-approved label for Neurontin lists common side effects including sleepiness, dizziness, and epilepsy.

Rare but serious side effects listed for Neurontin include allergic reactions, drowsiness, dizziness, seizures, suicidal behavior or ideation, and neuropsychiatric adverse events in children.

For more details about this treatment, visit:

Peripheral Neuropathy — Myeloma UK
https://www.myeloma.org.uk/wp-content/uploads/2...

Managing Treatment-Related Peripheral Neuropathy in Patients with Multiple Myeloma — OncologyNurseAdvisor
https://www.oncologynurseadvisor.com/home/cance...